PATH vs DBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

PATH

38.1
AI Score
VS
PATH Wins

DBX

33.6
AI Score

Investment Advisor Scores

PATH

38score
Recommendation
AVOID NEW MONEY

DBX

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PATH DBX Winner
Forward P/E 16.7224 10.846 DBX
PEG Ratio 0.4777 27.1157 PATH
Revenue Growth 13.4% 0.9% PATH
Earnings Growth 2280.8% -6.7% PATH
Tradestie Score 38.1/100 33.6/100 PATH
Profit Margin 21.0% 17.5% PATH
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

PATH 1M: +11.7% · 3M: +21.1% DBX 1M: +15.5% · 3M: +23.6%

Current Technical Phase

PATH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.1 · Price: $14.08

DBX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 66

RSI (14): 65.7 · Price: $37.74

Fundamentals Snapshot

Metric PATH DBX
Market Cap — —
Forward P/E 18.3 11.4
Trailing P/E 20.5 20.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin 0.1% 0.3%
EPS 0.67 1.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PATH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.